Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02222636
Other study ID # Sedation wei
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received August 14, 2014
Last updated August 19, 2014
Start date September 2014
Est. completion date December 2015

Study information

Verified date August 2014
Source Xijing Hospital
Contact n/a
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to explore the optimal protocol for dexmedetomidine used in children during perioperative period.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 2015
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Both
Age group 6 Months to 7 Years
Eligibility Inclusion Criteria:

- Written informed consent.

- Elective cleft lip and cleft palate repair surgery

- American Society of Anesthesiologists class I

- Aged between 6 months and 7 years old

Exclusion Criteria:

- Suspected or confirmed difficult airway

- History of upper respiratory tract infection with 1 month

- Combined with congenital heart disease

- Allergic to investigational products or with other contraindication

- Growth retardation or dysgnosia

- Central nervous system disease

- Serious infection

- Serious heart,brain,liver,kidney, pulmonary, and endocrine disease

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • The Efficacy and Safety of Intranasal Dexmedetomidine

Intervention

Drug:
Normal saline,1 milliliter
Normal saline,1 milliliter, 20 minutes before anaesthetic induction
Dexmedetomidine 1 µg.kg-1,1 milliliter
Dexmedetomidine 1 µg.kg-1,1 milliliter,20 minutes before anesthesia induction
Dexmedetomidine 2µg.kg-1,1 milliliter
Dexmedetomidine 2µg.kg-1,1 milliliter,20 minutes before anesthesia induction
Anesthesia induction, 8% sevoflurane
Inhalation induction with 8% sevoflurane
Anesthesia maintenance, 2%~3% sevoflurane,fentanyl
2%~3% sevoflurane,inhalation. fentanyl,2µg.kg-1.min-1,intravenous infusion

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Xijing Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Sedation-Agitation Scale The moment of entering operating room,20 minutes before anesthesia induction,10 minutes before anesthesia inducion,the moment of anesthesia induction No
Primary The pediatric anesthesia emergence delirium scale The moment of entering operating room,and from discontinuation of inhalational anesthetics to the moment of patient's consciousness recovery,an expected average of 1 hour No
Primary Anesthesia induction time From beginning of inhalating anesthetics to the moment of intubation No
Primary Anesthesia maintenance time From the moment of intubation to the discontinuation of inhalational anesthestics No
Primary Recovery time From discontinuation of inhalational anesthestics to the moment of patient's consciousness recovery, an expected average of 1 hour No
Primary Change from baseline in blood pressure during anesthesia The moment of entering operating room,20 minutes before anesthesia induction,10 minutes before anesthesia inducion,the moment of anesthesia induction Yes
Primary Change from baseline in heart rate during anesthesia The moment of entering operating room,20 minutes before anesthesia induction,10 minutes before anesthesia inducion,the moment of anesthesia induction Yes
Primary Change from baseline in respiratory rate during anesthesia The moment of entering operating room,20 minutes before anesthesia induction,10 minutes before anesthesia inducion,the moment of anesthesia induction Yes
Secondary The alveolar concentration of inhalational anesthetics the moment of anesthesia induction,the moment of intubation,before cutting skin Yes